Annemarie van der Aart-van der Beek
8PUBLICATIONS
26CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Feb 11, 2022
Kidney and heart failure outcomes associated with SGLT2 inhibitor use.Annemarie B van der Aart-van der Beek, Rudolf A de Boer, Hiddo J L Heerspink
|Apr 28, 2021
Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: A prespecified secondary analysis of a randomized controlled clinical trial.Charlotte C van Ruiten, Annemarie B van der Aart-van der Beek, Richard G IJzerman
|Apr 28, 2021
Renal haemodynamic response to sodium-glucose cotransporter-2 inhibition does not depend on protein intake: An analysis of three randomized controlled trials.Annemarie B van der Aart-van der Beek, David Cherney, Gozewijn D Laverman
|Feb 15, 2021
Evaluation of the Pharmacokinetics and Exposure-Response Relationship of Dapagliflozin in Patients without Diabetes and with Chronic Kidney Disease.Annemarie B van der Aart-van der Beek, Jeroen V Koomen, Claire C J Dekkers
|Aug 18, 2020
Effect of once-weekly exenatide on estimated glomerular filtration rate slope depends on baseline renal risk: A post hoc analysis of the EXSCEL trial.Annemarie B van der Aart-van der Beek, Lindsay E Clegg, Robert C Penland
Pageof 2
Frequent Collaborators
6 joint publications
Hiddo J L Heerspink
1 joint publications
Cristian Guja
1 joint publications
C David Sjöström
1 joint publications
Lindsay E Clegg
1 joint publications
Robert C Penland
1 joint publications
Rury R Holman
1 joint publications
David Cherney
1 joint publications
Charlotte C van Ruiten
1 joint publications
Richard G IJzerman
1 joint publications
Max Nieuwdorp